SEC Form 4 · accession 0001209191-16-133848
Audentes Therapeutics, Inc. · BOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis G Lange
Director
Period of report
Jul 25, 2016
Accepted (ET)
Jul 25, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628738
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 25, 2016 | C | 9,000 | — | A | 475,799 | D | |
| Common StockF1,F2 | Jul 25, 2016 | C | 13,400 | — | A | 87,343 | I | By Asset Management Ventures Fund, L.P. |
| Common StockF1,F3 | Jul 25, 2016 | C | 2,233 | — | A | 14,555 | I | By Camp Lowell Partners, LLC |
| Common StockF4 | holding | — | — | — | 25,678 | I | By Amygdala Lange Trust | |
| Common StockF5 | holding | — | — | — | 8,558 | I | By Lange Minors? Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred StockF1 | — | Jul 25, 2016 | C | 9,000 | D | — | — | Common Stock | 9,000 | 0 | D |
| Series B Preferred StockF1,F2 | — | Jul 25, 2016 | C | 13,400 | D | — | — | Common Stock | 13,400 | 0 | I |
| Series B Preferred StockF1,F3 | — | Jul 25, 2016 | C | 2,233 | D | — | — | Common Stock | 2,233 | 0 | I |
Explanation of responses
- F1Each share of the issuer's Series B Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering pursuant to a registration statement on Form S-1 (File No. 333-208842) under the Securities Act of 1933, as amended, and had no expiration date.
- F2The reporting person is a general partner of Asset Management Ventures Fund, L.P. ("AMVF L.L.P."), and has shared voting and dispositive power over the shares held by AMVF L.L.P. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- F3The reporting person is the president of Camp Lowell Partners, LLC ("Camp Lowell"), and has sole voting and dispositive power over the shares held by Camp Lowell. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- F4The reporting person's domestic partner is the trustee of the Amygdala Lange Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
- F5The reporting person's domestic partner is the trustee of the Lange Minors' Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.